HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

YZYBIO-B

4.130

0.000

Volume:- -

Turnover:- -

Market Cap:800.60M

PE:-8.20

High:4.130

Open:4.130

Low:4.130

Close:4.130

52wk High:8.400

52wk Low:4.000

Shares:193.85M

HK Float Shares:111.47M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.503

ROE:-704.81%

ROA:-18.74%

PB:-25.79

PE(LYR):-8.20

PS:4.74

Loading ...

Overview Company News Filings

YZYBIO-B (02496): Shi Jian Elected as Employee Representative Supervisor

Wuhan YZY Biopharma Appoints New Employee Representative Supervisor

YZYBIO-B (02496): Y225 (Emicizumab Injection) Receives IND Approval from NMPA

Wuhan YZY Biopharma - Y225 ‘‘Emicizumab Injection" Receives Ind Approval From Nmpa

THOMSON REUTERS

Wuhan YZY Biopharma Receives NMPA IND Approval for Y225 Emicizumab Injection

Wuhan YZY Biopharma (02496) Announces November 2025 Monthly Securities Movements

Bulletin Express

Trump Names Hassett as Potential Fed Chair Pick; Apple (AAPL.US) Hits Record High Again

Wuhan YZY Biopharma's Trial Results for Tumor Drug Published in International Journal

MT Newswires Live

Wuhan YZY Biopharma (2496) Publishes Phase II Data on M701 for Malignant Ascites in Renowned Journal

Bulletin Express

YZYBIO-B (02496) Publishes Phase II Data for M701 in Malignant Ascites in "Experimental Hematology & Oncology"

Wuhan YZY Biopharma Announces Phase II Results of M701 for Malignant Ascites Published in Experimental Hematology & Oncology

Wuhan YZY Biopharma (02496) Announces Monthly Return for October 2025

Bulletin Express

Wuhan YZY Biopharma Presents Phase II M701 Data for Malignant Pleural Effusion at ESMO 2025

YZYBIO-B (02496): Mid-Stage Data from Phase II Study of M701 for Malignant Pleural Effusion Presented at ESMO 2025

Wuhan YZY Biopharma (2496) Announces Interim Phase II Results of M701 for Malignant Pleural Effusion

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/02496/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02496","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02496\",,,,,undefined,":{"symbol":"02496","market":"HK","secType":"STK","nameCN":"YZYBIO-B","latestPrice":4.13,"timestamp":1774573260767,"preClose":4.13,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":111468814,"shares":193849200,"eps":-0.503479,"marketStatus":"Market Closed","change":0,"latestTime":"03-27 09:01:00","open":4.13,"high":4.13,"low":4.13,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":4.01,"bidSize":15000,"shortable":0,"etf":0,"ttmEps":-0.441123,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1774834200000},"marketStatusCode":7,"adr":0,"listingDate":1695571200000,"exchange":"SEHK","adjPreClose":4.13,"openAndCloseTimeList":[[1774575000000,1774584000000],[1774587600000,1774598400000]],"volumeRatio":0,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02496\",,,,,undefined,":{"symbol":"02496","floatShares":111468814,"roa":"-18.74%","roe":"-704.81%","lyrEps":-0.503479,"shares":193849200,"dividePrice":0,"high":4.13,"amplitude":0,"preClose":4.13,"low":4.13,"week52Low":4,"pbRate":"-25.79","psRate":"4.74","week52High":8.4,"institutionHeld":0,"latestPrice":4.13,"committee":1,"eps":-0.503479,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.441123,"open":4.13,"prevYearClose":8.02,"prevWeekClose":5.86,"prevMonthClose":6.52,"prevQuarterClose":8.02,"fiveDayClose":5.86,"twentyDayClose":6.52,"sixtyDayClose":6.99},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02496\",params:#limit:5,,,undefined,":[{"date":"2026-03-27","symbol":"02496","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774575000000,"name":null,"time":"","dateTimestamp":1774540800000,"actualEps":null},{"date":"2025-08-26","symbol":"02496","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null},{"date":"2025-03-28","symbol":"02496","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743125400000,"name":null,"time":"Post Market","dateTimestamp":1743091200000,"actualEps":null},{"date":"2024-08-29","symbol":"02496","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724895000000,"name":null,"time":"","dateTimestamp":1724860800000,"actualEps":null},{"date":"2024-03-28","symbol":"02496","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711589400000,"name":null,"time":"","dateTimestamp":1711555200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02496\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02496\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02496\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02496","date":"2026-03-27","current":-9.362468,"percent":0.365696,"low":-18.565593,"twenty":-14.332776,"median":-8.234591,"eighty":-6.936865,"high":-3.741546,"avg":-9.542365,"sd":3.822457,"marketCap":800597196},"quantilePoints":[{"date":"2023-09-22","current":-15.261024,"twenty":-15.274233,"median":-15.26928,"eighty":-15.264326,"marketCap":3088019200},{"date":"2023-09-29","current":-15.292224,"twenty":-17.099581,"median":-15.293234,"eighty":-15.280473,"marketCap":3049418960},{"date":"2023-10-06","current":-15.493216,"twenty":-15.501023,"median":-15.292224,"eighty":-15.050323,"marketCap":3088019200},{"date":"2023-10-13","current":-15.380625,"twenty":-15.493216,"median":-15.348538,"eighty":-15.261024,"marketCap":3060999032},{"date":"2023-10-20","current":-10.535817,"twenty":-15.418704,"median":-15.300038,"eighty":-14.801616,"marketCap":2093571360},{"date":"2023-10-27","current":-9.759574,"twenty":-15.417248,"median":-15.292224,"eighty":-11.937608,"marketCap":1938492000},{"date":"2023-11-03","current":-9.733728,"twenty":-15.412338,"median":-15.155674,"eighty":-10.478048,"marketCap":1938492000},{"date":"2023-11-10","current":-8.275398,"twenty":-15.390041,"median":-14.508961,"eighty":-9.494912,"marketCap":1647718200},{"date":"2023-11-17","current":-8.703164,"twenty":-15.38145,"median":-11.695259,"eighty":-8.750672,"marketCap":1748519784},{"date":"2023-11-24","current":-8.421561,"twenty":-15.329285,"median":-10.573898,"eighty":-8.701771,"marketCap":1705872960},{"date":"2023-12-01","current":-7.919793,"twenty":-15.30332,"median":-10.003273,"eighty":-8.541365,"marketCap":1610886852},{"date":"2023-12-08","current":-8.497372,"twenty":-15.294595,"median":-9.516549,"eighty":-8.420238,"marketCap":1721380896},{"date":"2023-12-15","current":-8.258301,"twenty":-15.292426,"median":-9.276148,"eighty":-8.274722,"marketCap":1682611056},{"date":"2023-12-22","current":-8.349506,"twenty":-15.280473,"median":-8.776546,"eighty":-8.277258,"marketCap":1700057484},{"date":"2023-12-29","current":-8.428335,"twenty":-15.270931,"median":-8.740745,"eighty":-8.306436,"marketCap":1725257880},{"date":"2024-01-05","current":-8.249766,"twenty":-15.218884,"median":-8.699682,"eighty":-8.272694,"marketCap":1676795580},{"date":"2024-01-12","current":-8.302569,"twenty":-15.000582,"median":-8.571321,"eighty":-8.275563,"marketCap":1688426532},{"date":"2024-01-19","current":-8.113537,"twenty":-14.743085,"median":-8.513713,"eighty":-8.272694,"marketCap":1647718200},{"date":"2024-01-26","current":-7.982332,"twenty":-14.471602,"median":-8.481448,"eighty":-8.258393,"marketCap":1614763836},{"date":"2024-02-02","current":-7.992522,"twenty":-13.915342,"median":-8.424948,"eighty":-8.196137,"marketCap":1614763836},{"date":"2024-02-09","current":-8.02019,"twenty":-12.050937,"median":-8.406699,"eighty":-8.080173,"marketCap":1628333280},{"date":"2024-02-16","current":-8.343013,"twenty":-11.339581,"median":-8.370574,"eighty":-8.105196,"marketCap":1694242008},{"date":"2024-02-23","current":-8.30086,"twenty":-10.803844,"median":-8.369483,"eighty":-8.124586,"marketCap":1676795580},{"date":"2024-03-01","current":-8.247733,"twenty":-10.604956,"median":-8.362825,"eighty":-8.153154,"marketCap":1667103120},{"date":"2024-03-08","current":-8.186551,"twenty":-10.543433,"median":-8.343013,"eighty":-8.173812,"marketCap":1655472168},{"date":"2024-03-15","current":-8.155425,"twenty":-10.30474,"median":-8.311389,"eighty":-8.173276,"marketCap":1647718200},{"date":"2024-03-22","current":-7.39462,"twenty":-9.857053,"median":-8.302569,"eighty":-8.105196,"marketCap":1492638840},{"date":"2024-03-28","current":-7.61103,"twenty":-9.744066,"median":-8.301568,"eighty":-8.043049,"marketCap":1531408680},{"date":"2024-04-05","current":-7.288366,"twenty":-9.690292,"median":-8.300787,"eighty":-8.021295,"marketCap":1512023760},{"date":"2024-04-12","current":-6.976051,"twenty":-9.494912,"median":-8.295352,"eighty":-7.983468,"marketCap":1448053524},{"date":"2024-04-19","current":-6.963318,"twenty":-9.388856,"median":-8.276973,"eighty":-7.977458,"marketCap":1444176540},{"date":"2024-04-26","current":-6.971914,"twenty":-9.296949,"median":-8.272018,"eighty":-7.930221,"marketCap":1444176540},{"date":"2024-05-03","current":-6.976736,"twenty":-9.241479,"median":-8.264756,"eighty":-7.6347,"marketCap":1444176540},{"date":"2024-05-10","current":-6.960212,"twenty":-8.933122,"median":-8.256463,"eighty":-7.598809,"marketCap":1444176540},{"date":"2024-05-17","current":-6.970443,"twenty":-8.807861,"median":-8.251559,"eighty":-7.39462,"marketCap":1444176540},{"date":"2024-05-24","current":-7.095514,"twenty":-8.76114,"median":-8.247733,"eighty":-7.267873,"marketCap":1444176540},{"date":"2024-05-31","current":-7.0883,"twenty":-8.730819,"median":-8.237322,"eighty":-7.171233,"marketCap":1444176540},{"date":"2024-06-07","current":-7.097101,"twenty":-8.707372,"median":-8.195562,"eighty":-7.097101,"marketCap":1444176540},{"date":"2024-06-14","current":-7.132215,"twenty":-8.698985,"median":-8.193432,"eighty":-7.097238,"marketCap":1449992016},{"date":"2024-06-21","current":-7.988022,"twenty":-8.625304,"median":-8.18531,"eighty":-7.098087,"marketCap":1620579312},{"date":"2024-06-28","current":-7.48471,"twenty":-8.574009,"median":-8.177364,"eighty":-7.098775,"marketCap":1517839236},{"date":"2024-07-05","current":-7.715801,"twenty":-8.562528,"median":-8.159606,"eighty":-7.101937,"marketCap":1564363044},{"date":"2024-07-12","current":-7.141207,"twenty":-8.536784,"median":-8.120442,"eighty":-7.107036,"marketCap":1449992016},{"date":"2024-07-19","current":-7.131527,"twenty":-8.514561,"median":-8.053748,"eighty":-7.107036,"marketCap":1448053524},{"date":"2024-07-26","current":-7.10513,"twenty":-8.504633,"median":-8.029564,"eighty":-7.105677,"marketCap":1448053524},{"date":"2024-08-02","current":-7.109273,"twenty":-8.491002,"median":-8.019114,"eighty":-7.105677,"marketCap":1448053524},{"date":"2024-08-09","current":-7.033842,"twenty":-8.475712,"median":-7.991974,"eighty":-7.097834,"marketCap":1442238048},{"date":"2024-08-16","current":-6.879903,"twenty":-8.451599,"median":-7.985142,"eighty":-7.095806,"marketCap":1411222176},{"date":"2024-08-23","current":-6.041633,"twenty":-8.425625,"median":-7.981406,"eighty":-7.090359,"marketCap":1244511864},{"date":"2024-08-30","current":-6.047183,"twenty":-8.418914,"median":-7.97694,"eighty":-7.085583,"marketCap":1219311468},{"date":"2024-09-06","current":-6.034663,"twenty":-8.411646,"median":-7.942728,"eighty":-7.024202,"marketCap":1217372976},{"date":"2024-09-13","current":-6.050501,"twenty":-8.400619,"median":-7.919793,"eighty":-6.989131,"marketCap":1217372976},{"date":"2024-09-20","current":-5.899508,"twenty":-8.390451,"median":-7.809695,"eighty":-6.977241,"marketCap":1194111072},{"date":"2024-09-27","current":-5.635763,"twenty":-8.383344,"median":-7.722148,"eighty":-6.974189,"marketCap":1147587264},{"date":"2024-10-04","current":-6.646499,"twenty":-8.371665,"median":-7.71452,"eighty":-6.971914,"marketCap":1347251940},{"date":"2024-10-10","current":-6.670566,"twenty":-8.369919,"median":-7.665604,"eighty":-6.970443,"marketCap":1343374956},{"date":"2024-10-18","current":-5.989499,"twenty":-8.366581,"median":-7.61103,"eighty":-6.964903,"marketCap":1199926548},{"date":"2024-10-25","current":-5.941495,"twenty":-8.363757,"median":-7.592567,"eighty":-6.963278,"marketCap":1190234088},{"date":"2024-11-01","current":-5.753759,"twenty":-8.362581,"median":-7.48471,"eighty":-6.932913,"marketCap":1153402740},{"date":"2024-11-08","current":-5.323409,"twenty":-8.352088,"median":-7.478194,"eighty":-6.706839,"marketCap":1062293616},{"date":"2024-11-15","current":-4.810927,"twenty":-8.344312,"median":-7.39462,"eighty":-6.66868,"marketCap":949861080},{"date":"2024-11-22","current":-4.597104,"twenty":-8.320901,"median":-7.288282,"eighty":-6.614502,"marketCap":907214256},{"date":"2024-11-29","current":-4.511723,"twenty":-8.314189,"median":-7.193914,"eighty":-6.4628,"marketCap":889767828},{"date":"2024-12-06","current":-3.832688,"twenty":-8.309887,"median":-7.189483,"eighty":-6.054759,"marketCap":754073388},{"date":"2024-12-13","current":-3.741546,"twenty":-8.30727,"median":-7.147179,"eighty":-6.049837,"marketCap":734688468},{"date":"2024-12-20","current":-3.946605,"twenty":-8.303428,"median":-7.141207,"eighty":-6.034627,"marketCap":771519816},{"date":"2024-12-27","current":-6.936731,"twenty":-8.302316,"median":-7.140369,"eighty":-6.034555,"marketCap":1355005908},{"date":"2025-01-03","current":-7.8123,"twenty":-8.301863,"median":-7.141207,"eighty":-6.034663,"marketCap":1527531696},{"date":"2025-01-10","current":-7.782302,"twenty":-8.301426,"median":-7.145546,"eighty":-6.036057,"marketCap":1515900744},{"date":"2025-01-17","current":-7.348445,"twenty":-8.300831,"median":-7.189317,"eighty":-6.042743,"marketCap":1432545588},{"date":"2025-01-24","current":-7.302687,"twenty":-8.300293,"median":-7.192391,"eighty":-6.047847,"marketCap":1432545588},{"date":"2025-01-28","current":-7.264616,"twenty":-8.299451,"median":-7.229265,"eighty":-6.049174,"marketCap":1432545588},{"date":"2025-02-07","current":-7.236748,"twenty":-8.296655,"median":-7.256521,"eighty":-6.050501,"marketCap":1418976144},{"date":"2025-02-14","current":-6.936954,"twenty":-8.289567,"median":-7.234585,"eighty":-6.050566,"marketCap":1356944400},{"date":"2025-02-21","current":-6.209204,"twenty":-8.280918,"median":-7.193914,"eighty":-6.051176,"marketCap":1221249960},{"date":"2025-02-28","current":-5.735312,"twenty":-8.276823,"median":-7.189483,"eighty":-6.049174,"marketCap":1124325360},{"date":"2025-03-07","current":-4.382772,"twenty":-8.275728,"median":-7.147179,"eighty":-6.034591,"marketCap":862628940},{"date":"2025-03-14","current":-4.381178,"twenty":-8.27337,"median":-7.141207,"eighty":-6.005336,"marketCap":862628940},{"date":"2025-03-21","current":-4.382899,"twenty":-8.271865,"median":-7.139645,"eighty":-5.976203,"marketCap":862628940},{"date":"2025-03-28","current":-6.03007,"twenty":-8.267559,"median":-7.132215,"eighty":-5.958282,"marketCap":1184418612},{"date":"2025-04-03","current":-12.27285,"twenty":-8.275893,"median":-7.137062,"eighty":-5.959979,"marketCap":1279404720},{"date":"2025-04-11","current":-11.044555,"twenty":-8.297306,"median":-7.141207,"eighty":-5.971601,"marketCap":1143710280},{"date":"2025-04-17","current":-8.683774,"twenty":-8.301426,"median":-7.143912,"eighty":-5.986226,"marketCap":901398780},{"date":"2025-04-25","current":-8.769575,"twenty":-8.306866,"median":-7.147536,"eighty":-5.989499,"marketCap":911091240},{"date":"2025-05-02","current":-8.750975,"twenty":-8.320901,"median":-7.189649,"eighty":-5.997241,"marketCap":911091240},{"date":"2025-05-09","current":-8.320184,"twenty":-8.320865,"median":-7.193914,"eighty":-5.999307,"marketCap":872321400},{"date":"2025-05-16","current":-7.720916,"twenty":-8.320762,"median":-7.234585,"eighty":-6.005336,"marketCap":816105132},{"date":"2025-05-23","current":-7.734459,"twenty":-8.320415,"median":-7.256521,"eighty":-6.010152,"marketCap":819982116},{"date":"2025-05-30","current":-7.700604,"twenty":-8.317297,"median":-7.263991,"eighty":-6.01222,"marketCap":819982116},{"date":"2025-06-06","current":-7.681007,"twenty":-8.314485,"median":-7.286363,"eighty":-6.02333,"marketCap":819982116},{"date":"2025-06-13","current":-9.456792,"twenty":-8.320762,"median":-7.288884,"eighty":-6.03007,"marketCap":1009954332},{"date":"2025-06-20","current":-9.38443,"twenty":-8.354671,"median":-7.302687,"eighty":-6.032718,"marketCap":1000261872},{"date":"2025-06-27","current":-8.886685,"twenty":-8.370356,"median":-7.33658,"eighty":-6.034591,"marketCap":949861080},{"date":"2025-07-04","current":-8.886268,"twenty":-8.400619,"median":-7.39462,"eighty":-6.034663,"marketCap":949861080},{"date":"2025-07-11","current":-9.439834,"twenty":-8.450162,"median":-7.477671,"eighty":-6.037451,"marketCap":1008015840},{"date":"2025-07-18","current":-10.71898,"twenty":-8.504633,"median":-7.483524,"eighty":-6.043853,"marketCap":1143710280},{"date":"2025-07-25","current":-10.354306,"twenty":-8.575353,"median":-7.586326,"eighty":-6.04851,"marketCap":1108817424},{"date":"2025-08-01","current":-10.200109,"twenty":-8.700378,"median":-7.607601,"eighty":-6.050501,"marketCap":1085555520},{"date":"2025-08-08","current":-10.174658,"twenty":-8.73051,"median":-7.6347,"eighty":-6.050545,"marketCap":1085555520},{"date":"2025-08-15","current":-10.189926,"twenty":-8.755577,"median":-7.668855,"eighty":-6.050988,"marketCap":1085555520},{"date":"2025-08-22","current":-10.404516,"twenty":-8.778653,"median":-7.696508,"eighty":-6.053156,"marketCap":1104940440},{"date":"2025-08-29","current":-12.496435,"twenty":-8.886268,"median":-7.699076,"eighty":-6.05556,"marketCap":1066170600},{"date":"2025-09-05","current":-12.508831,"twenty":-8.917527,"median":-7.704882,"eighty":-6.055623,"marketCap":1066170600},{"date":"2025-09-12","current":-12.713379,"twenty":-9.283082,"median":-7.709288,"eighty":-6.056629,"marketCap":1085555520},{"date":"2025-09-19","current":-13.812899,"twenty":-9.372197,"median":-7.711903,"eighty":-6.091088,"marketCap":1178603136},{"date":"2025-09-26","current":-15.488824,"twenty":-9.421871,"median":-7.713577,"eighty":-6.168118,"marketCap":1318174560},{"date":"2025-10-03","current":-15.429223,"twenty":-9.439834,"median":-7.716349,"eighty":-6.209251,"marketCap":1316236068},{"date":"2025-10-10","current":-15.542765,"twenty":-9.48241,"median":-7.718907,"eighty":-6.209438,"marketCap":1323990036},{"date":"2025-10-17","current":-15.463777,"twenty":-9.516549,"median":-7.722508,"eighty":-6.564001,"marketCap":1316236068},{"date":"2025-10-24","current":-16.141138,"twenty":-9.993637,"median":-7.727404,"eighty":-6.587794,"marketCap":1374390828},{"date":"2025-10-31","current":-15.935241,"twenty":-10.174658,"median":-7.732892,"eighty":-6.604283,"marketCap":1358882892},{"date":"2025-11-07","current":-15.945201,"twenty":-10.180758,"median":-7.758053,"eighty":-6.609789,"marketCap":1358882892},{"date":"2025-11-14","current":-15.900146,"twenty":-10.200109,"median":-7.784219,"eighty":-6.614502,"marketCap":1358882892},{"date":"2025-11-21","current":-16.089098,"twenty":-10.29964,"median":-7.809695,"eighty":-6.640318,"marketCap":1374390828},{"date":"2025-11-28","current":-16.030869,"twenty":-10.386607,"median":-7.849274,"eighty":-6.646499,"marketCap":1374390828},{"date":"2025-12-05","current":-16.003355,"twenty":-10.404516,"median":-7.919793,"eighty":-6.658209,"marketCap":1374390828},{"date":"2025-12-12","current":-15.973808,"twenty":-10.577045,"median":-7.942728,"eighty":-6.66868,"marketCap":1374390828},{"date":"2025-12-19","current":-15.93625,"twenty":-10.714182,"median":-7.97694,"eighty":-6.670691,"marketCap":1374390828},{"date":"2025-12-24","current":-15.662693,"twenty":-10.90375,"median":-7.980005,"eighty":-6.674625,"marketCap":1355005908},{"date":"2026-01-02","current":-17.543083,"twenty":-11.095447,"median":-7.982691,"eighty":-6.684863,"marketCap":1523654712},{"date":"2026-01-09","current":-17.49951,"twenty":-11.336885,"median":-7.988022,"eighty":-6.703505,"marketCap":1523654712},{"date":"2026-01-16","current":-17.442827,"twenty":-12.451475,"median":-7.994219,"eighty":-6.740071,"marketCap":1523654712},{"date":"2026-01-23","current":-17.215232,"twenty":-12.506134,"median":-8.02019,"eighty":-6.870823,"marketCap":1502331300},{"date":"2026-01-30","current":-17.402236,"twenty":-12.672793,"median":-8.041443,"eighty":-6.879903,"marketCap":1525593204},{"date":"2026-02-06","current":-16.762691,"twenty":-13.116393,"median":-8.071832,"eighty":-6.881774,"marketCap":1473253920},{"date":"2026-02-13","current":-15.877471,"twenty":-13.767462,"median":-8.141386,"eighty":-6.889262,"marketCap":1403468208},{"date":"2026-02-20","current":-15.900374,"twenty":-14.02108,"median":-8.157515,"eighty":-6.889266,"marketCap":1403468208},{"date":"2026-02-27","current":-15.727885,"twenty":-14.413548,"median":-8.177364,"eighty":-6.902973,"marketCap":1403468208},{"date":"2026-03-06","current":-12.483086,"twenty":-14.626023,"median":-8.18531,"eighty":-6.913266,"marketCap":1104940440},{"date":"2026-03-13","current":-12.425855,"twenty":-14.413548,"median":-8.193432,"eighty":-6.925983,"marketCap":1104940440},{"date":"2026-03-20","current":-12.823206,"twenty":-14.349192,"median":-8.196999,"eighty":-6.935617,"marketCap":1135956312},{"date":"2026-03-27","current":-9.060567,"twenty":-14.332776,"median":-8.234591,"eighty":-6.936865,"marketCap":800597196}],"updateTime":1774723244731},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02496\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1138960874","title":"YZYBIO-B (02496): Shi Jian Elected as Employee Representative Supervisor","url":"https://stock-news.laohu8.com/highlight/detail?id=1138960874","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138960874?lang=en_us&edition=fundamental","pubTime":"2025-12-31 12:58","pubTimestamp":1767157097,"startTime":"0","endTime":"0","summary":"Dr. Wang Tao has resigned from his position as Employee Representative Supervisor of the company for personal career development reasons, effective December 31, 2025. Dr. Shi Jian, Director of the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496","BK1161"],"gpt_icon":0},{"id":"2595728216","title":"Wuhan YZY Biopharma Appoints New Employee Representative Supervisor","url":"https://stock-news.laohu8.com/highlight/detail?id=2595728216","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595728216?lang=en_us&edition=fundamental","pubTime":"2025-12-31 12:53","pubTimestamp":1767156820,"startTime":"0","endTime":"0","summary":"Wuhan YZY Biopharma Co. Ltd. has announced the resignation of Dr. Wang Tao as employee representative supervisor and the appointment of Dr. Shi as the new employee representative supervisor. The company’s board and its composition remain otherwise unchanged.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuhan Yzy Biopharma Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 31, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251231:nNDL1dl924:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02496"],"gpt_icon":0},{"id":"1108970514","title":"YZYBIO-B (02496): Y225 (Emicizumab Injection) Receives IND Approval from NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=1108970514","media":"Stock News","labels":["productRelease","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108970514?lang=en_us&edition=fundamental","pubTime":"2025-12-24 19:38","pubTimestamp":1766576310,"startTime":"0","endTime":"0","summary":"YZYBIO-B (02496) announced on December 23, 2025, that its biosimilar drug Y225 has received Investigational New Drug (IND) approval from China's National Medical Products Administration (NMPA). Y225...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02496","IND"],"gpt_icon":0},{"id":"2593471343","title":"Wuhan YZY Biopharma  - Y225 ‘‘Emicizumab Injection\" Receives Ind Approval From Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2593471343","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593471343?lang=en_us&edition=fundamental","pubTime":"2025-12-24 19:33","pubTimestamp":1766576028,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251224:nFWN3XU03D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02496"],"gpt_icon":0},{"id":"2593713404","title":"Wuhan YZY Biopharma Receives NMPA IND Approval for Y225 Emicizumab Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2593713404","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593713404?lang=en_us&edition=fundamental","pubTime":"2025-12-24 19:33","pubTimestamp":1766576009,"startTime":"0","endTime":"0","summary":"Wuhan YZY Biopharma Co., Ltd. has announced that its Y225 \"Emicizumab Injection\" has received Investigational New Drug  approval from the National Medical Products Administration  of China. The approved clinical trial will evaluate the bioequivalence of Hemlibra and Y225 in healthy adult male subjects. This milestone positions Y225 as a potential first biosimilar of Hemlibra to be launched in China, aiming to address the domestic gap in high-barrier bispecific monoclonal antibody biosimilars.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuhan Yzy Biopharma Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 24, 2025, a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251224:nNDL2hMmWX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02496"],"gpt_icon":0},{"id":"1186066248","title":"Wuhan YZY Biopharma (02496) Announces November 2025 Monthly Securities Movements","url":"https://stock-news.laohu8.com/highlight/detail?id=1186066248","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186066248?lang=en_us&edition=fundamental","pubTime":"2025-12-04 16:44","pubTimestamp":1764837874,"startTime":"0","endTime":"0","summary":"Wuhan YZY Biopharma Co., Ltd. (Stock code: 02496) released its Monthly Return on Movements in Securities for the period ended 30 November 2025. The total authorised and registered share capital...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"gpt_icon":0},{"id":"1142541938","title":"Trump Names Hassett as Potential Fed Chair Pick; Apple (AAPL.US) Hits Record High Again","url":"https://stock-news.laohu8.com/highlight/detail?id=1142541938","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142541938?lang=en_us&edition=fundamental","pubTime":"2025-12-03 07:22","pubTimestamp":1764717748,"startTime":"0","endTime":"0","summary":"**Key Highlights**   U.S. President Donald Trump stated on Tuesday that he plans to announce his nominee for the next Federal Reserve chair in early 2026, unexpectedly naming National Economic...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"9386c6f4635d5f84ecd5a4675366ad45","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673691.USD","02496","LU2089284900.SGD","IE00BN29S564.USD","BK1116","LU2602419157.SGD","LU0545039389.USD","IE00BFSS7M15.SGD","LU1582987597.SGD","LU0203201768.USD","LU0868494708.USD","BK4515","IE0004091025.USD","LU0795875086.SGD","LU2236285917.USD","LU1084165304.USD","LU0157215616.USD","02693","IE00B3SWFQ91.USD","LU0444973449.USD","OEX","LU2381873111.SGD","LU2750360641.GBP","LU0096364046.USD","LU2360106780.USD","LU0672654240.SGD","SPY","LU2403377893.USD","LU1066053197.SGD","LU0154236417.USD","LU2065170008.USD","LU2430703095.HKD","IE00B7KXQ091.USD","LU2023250330.USD","SG9999015986.USD","LU0251132253.USD","BK4170","GB00BDT5M118.USD","LU0965508806.USD","LU0640476718.USD","LU0234572021.USD","LU0158827781.USD","SPXU","IE00BJTD4V19.USD","SG9999017495.SGD","LU1037948897.HKD","SG9999014559.SGD","IE00B775H168.HKD","LU0080751232.USD","SG9999015952.SGD","02539","BK4573","HK0000320223.HKD","LU0170899867.USD","LU1935043536.SGD","LU2471134952.CNY","LU0494093205.USD","LU0354030438.USD","LU2430703251.USD","LU1642822529.SGD","LU1206712785.SGD","LU0788109477.HKD","IE00B19Z8W00.USD","LU2108987350.USD","LU0784385840.USD","LU1868837300.USD","IE0003U64NQ7.SGD","LU1804176565.USD","SH","LU0256863902.USD","IE00B5949003.HKD","BK4554","LU0476273544.USD","LU1232071149.USD","LU2111349929.HKD","LU1732799900.SGD","LU1119994496.HKD","LU0511384066.AUD","LU2247934214.USD","LU1035775433.USD","LU0345769128.USD","LU2860962120.EUR","LU2458330169.SGD","LU2250418816.HKD","LU2063271972.USD","IE0009356076.USD","IVV","LU1917777945.USD","LU1935042488.USD","IE00BK4W5L77.USD","LU2168563687.JPY","LU0444971666.USD","LU0882574139.USD","LU0149725797.USD","LU2361044949.HKD","IE00BJJMRX11.SGD","IE000W1ABFV2.USD","LU0472753341.HKD","IE00BSNM7G36.USD","LU0456855351.SGD","IE00B1XK9C88.USD","LU1127390331.HKD","LU0979878070.USD","LU2750360997.AUD","LU2023251221.USD","IE00B1BXHZ80.USD","LU1267930730.SGD","LU0203202063.USD","LU0985320562.USD","LU0823421333.USD","LU0323591593.USD","LU1974910355.USD","IE00BN8TJ469.HKD","LU0820562030.AUD","SGXZ31699556.SGD","LU1778281490.HKD","LU1069344957.HKD","LU1244550577.SGD","LU2106854487.HKD","SG9999014542.SGD","BK4534","LU2420271590.USD","LU2242650005.HKD","LU0689626769.HKD","LU0957808578.USD","LU0053666078.USD","LU0345768740.USD","SG9999014898.SGD","LU0820561909.HKD","LU1571399168.USD","LU2092627202.USD","LU1868837136.USD","LU2089283258.USD","LU2471134523.USD","AAPL","LU1791710582.SGD","BK4598","LU1291159041.SGD","LU1732800096.USD","LU0417517546.SGD","IE00BK4W5M84.HKD","BK4592","LU0957791311.USD","LU2756315664.SGD","LU0109391861.USD","LU0070217475.USD","LU2028103732.USD","LU0210528500.USD","LU2417539215.USD","LU0234570918.USD","LU1244550221.USD","LU0082616367.USD","LU2097344357.USD","LU2083900584.USD","LU1046421795.USD","LU0708995401.HKD","LU1280957306.USD","BK4574","LU1935042215.USD","LU2237443382.USD","LU2265009873.SGD","SG9999014906.USD","LU1116320737.USD","LU2452424414.USD","SG9999018857.SGD","LU0353189680.USD","LU2087625088.SGD","LU2360032135.SGD","BK4527","LU1699723380.USD","LU0965509283.SGD","LU0069063385.USD","LU0289961442.SGD","LU1003077747.HKD","OEF","LU0124676726.USD","SG9999001424.SGD","IE00BJTD4N35.SGD","IE0001KFT4U8.USD","LU2023250504.SGD","LU0719512351.SGD","LU2286300806.USD","IE00BJLML261.HKD","SG9999015341.SGD","LU1582986433.USD","LU0267386448.USD","ESmain","IE00B3S45H60.SGD","LU0889565833.HKD","LU0949170772.SGD","BK4501","LU0072462426.USD","LU0466842654.USD","LU2361045086.USD","LU2746668461.USD","LU0345769631.USD","IE0009G5SDU7.USD","LU2242649171.HKD","LU2552382058.USD","LU1582987324.SGD","LU2023250843.SGD","BK4550","LU2347655156.SGD","LU2487616109.SGD","LU1316542783.SGD","LU0314104364.USD","LU2191332357.HKD","UPRO","LU0820561818.USD","LU2097344431.USD","LU0198837287.USD","LU2756315318.SGD","LU0265550946.USD","SG9999000418.SGD","LU1868836757.USD","LU1989764664.SGD","LU2543165471.USD","MACW.SI","BK4588","BK4579","LU1496350502.SGD","IE0004445239.USD","LU1720051108.HKD","LU0786609619.USD","LU1551013425.SGD","LU1366333091.USD","LU1989771016.USD","BK4585","IE000ITXATA3.USD","BK1161","LU0057025933.USD","LU2505996509.AUD","LU2237443465.HKD","LU0353189763.USD","LU1496350171.SGD","LU0265550359.USD","SG9999015945.SGD","SG9999015978.USD","IE00BFSS8Q28.SGD","LU1066051225.USD","LU1235294995.USD","LU1242518931.SGD","LU0943347566.SGD","BK4512","LU2430703178.SGD","LU1814569148.SGD","LU2237443978.SGD","LU2125154935.USD","IE00BWXC8680.SGD","LU0210536198.USD","LU1989772840.SGD","LU1206713676.USD","SSO","IE00B4YYXB79.USD","LU0683600562.USD","BK4532","BK4507","LU1868836591.USD","SDS","LU2087621335.USD","LU2347655073.USD","01729","LU0726765562.USD","LU0048584097.USD","BK4553","LU0077335932.USD","IE000YTNTUN2.SGD","LU2065171311.SGD","LU0354030511.USD","IE00BJJMRY28.SGD","LU2168564222.USD","LU1242518857.USD","LU1629891620.HKD","SG9999015358.SGD","IE0004086264.USD","LU0823434583.USD","LU2357305700.SGD","IE0005OL40V9.USD","LU2168564149.EUR","LU2896262040.SGD","IE00BKVL7J92.USD","LU0823434740.USD","LU1366192091.USD","LU0127658192.USD","LU2456880835.USD","LU0868494617.USD","SG9999014567.USD","LU2237438978.USD","LU2505996681.GBP","LU2592432038.USD","LU0642271901.SGD","LU2458330243.SGD","LU1261432733.SGD","LU1935043023.USD","LU2054465674.USD","LU0795875169.SGD","LU0964807845.USD","BK4504","LU1989764748.USD","LU2125154778.USD","LU1803068979.SGD","BK4571","LU0056508442.USD","LU0158827948.USD","LU2461242641.AUD","LU2237443622.USD","LU2361044865.SGD","IE00B4JS1V06.HKD","SG9999002232.USD","LU2092937148.SGD","LU0345770993.USD","LU0011850046.USD","IE00BLSP4239.USD","LU0942090050.USD","LU2271345857.HKD","HK0000320264.USD","LU1116320901.HKD","LU0784385170.HKD","BK4575","LU2552382215.SGD","LU1934455863.HKD","IE00BKDWB100.SGD","LU0348723411.USD","LU1301847155.USD","LU2168564495.EUR","LU0787776722.HKD","SG9999014575.USD","LU0528227936.USD","LU0210533765.USD","IE00BBT3K403.USD","LU1548497426.USD","LU0061475181.USD","LU1551013342.USD","LU0215105999.USD","LU1506573853.SGD","LU1935042991.SGD","SG9999014914.USD","LU1839511570.USD","LU0256863811.USD","LU2065169927.USD","IE000KEQY171.SGD","IE00B19Z8X17.USD","LU0861579265.USD","LU1145028129.USD","HK0000306701.USD","LU2065171402.SGD","BK4533","IE0004445015.USD","LU0096362180.USD","LU0079474960.USD","BK4559","LU0912757837.SGD","LU1066051498.USD","LU1791710400.SGD","IE0034235303.USD","LU0689472784.USD","LU2746668974.SGD","LU2237443895.HKD","LU0109392836.USD","HK0000306685.HKD","LU0661504455.SGD","LU0345768153.USD","LU1934455277.USD","BK4566","LU1868836914.USD","LU0823421416.USD","LU0238689110.USD",".SPX","LU0965509101.SGD","LU0553294199.USD","IE00BZ1G4Q59.USD","LU2077746001.SGD","LU2168564065.EUR","LU1674673428.USD","LU2237443549.SGD","LU0320765059.SGD","IE00B19Z9505.USD","LU1582986359.USD","LU0949170426.SGD","BK1163","LU1934455194.USD","LU0061474960.USD","LU2552382132.HKD","LU1720051017.SGD","LU1815336760.USD","LU1718418525.SGD","LU1823568750.SGD","LU1066051811.HKD","LU0308772762.SGD","BK4576","LU2462157665.USD","LU0784384876.USD","LU0724617625.USD","LU0289739343.SGD","LU1989772923.USD","LU1914381329.SGD","LU2213496289.HKD","IE00B775SV38.USD","SG9999018865.SGD","SG9999002224.SGD","LU0345770308.USD","SG9999014880.SGD","BK4581","02533","LU1815333072.USD","LU2471134796.USD","LU0314106906.USD","LU1244550494.USD","LU2133065610.SGD","LU2471134879.HKD","LU0316494557.USD","IE00BLSP4452.SGD","LU0738911758.USD","LU0965509010.AUD","BK4505","MESmain","LU1852331112.SGD","LU0097036916.USD","LU0784383803.USD","LU1037948541.HKD"],"gpt_icon":1},{"id":"2588373770","title":"Wuhan YZY Biopharma's Trial Results for Tumor Drug Published in International Journal","url":"https://stock-news.laohu8.com/highlight/detail?id=2588373770","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588373770?lang=en_us&edition=fundamental","pubTime":"2025-12-02 19:30","pubTimestamp":1764675000,"startTime":"0","endTime":"0","summary":"Wuhan YZY Biopharma  said development and clinical trial results of M701 have been published in internationally renowned medical journal Experimental Hematology & Oncology, a Tuesday Hong Kong bourse filing said.The drug is for the treatment of malignant ascites caused by advanced epithelial tumors in China.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02496","BK1161"],"gpt_icon":0},{"id":"1111826408","title":"Wuhan YZY Biopharma (2496) Publishes Phase II Data on M701 for Malignant Ascites in Renowned Journal","url":"https://stock-news.laohu8.com/highlight/detail?id=1111826408","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111826408?lang=en_us&edition=fundamental","pubTime":"2025-12-02 18:24","pubTimestamp":1764671076,"startTime":"0","endTime":"0","summary":"Wuhan YZY Biopharma Co., Ltd. (Stock Code: 2496) announced that clinical trial results for M701, a bispecific antibody drug candidate targeting epithelial cell adhesion molecule (EpCAM) and cluster...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"gpt_icon":0},{"id":"1143701033","title":"YZYBIO-B (02496) Publishes Phase II Data for M701 in Malignant Ascites in \"Experimental Hematology & Oncology\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1143701033","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143701033?lang=en_us&edition=fundamental","pubTime":"2025-12-02 18:16","pubTimestamp":1764670584,"startTime":"0","endTime":"0","summary":"YZYBIO-B (02496) announced that the development and clinical trial results of its self-developed bispecific antibody (BsAb) drug M701, targeting epithelial cell adhesion molecule (EpCAM) and CD3, for...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02496"],"gpt_icon":0},{"id":"2588316670","title":"Wuhan YZY Biopharma Announces Phase II Results of M701 for Malignant Ascites Published in Experimental Hematology & Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2588316670","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588316670?lang=en_us&edition=fundamental","pubTime":"2025-12-02 18:06","pubTimestamp":1764670013,"startTime":"0","endTime":"0","summary":"Wuhan YZY Biopharma Co., Ltd. has announced that the Phase II clinical trial data for its bispecific antibody  drug candidate M701, which targets epithelial cell adhesion molecule  and cluster of differentiation 3 , has been published in the international medical journal Experimental Hematology & Oncology. The study evaluated the efficacy and safety of M701 for the treatment of malignant ascites caused by advanced epithelial tumors in China. The company noted that this publication marks recognition of the clinical value of M701 in the international medical community. Wuhan YZY Biopharma emphasized that there is no guarantee M701 will ultimately be successfully developed and marketed, and advised shareholders and potential investors to exercise caution.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and shou","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL2TDPPD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02496"],"gpt_icon":0},{"id":"1112558527","title":"Wuhan YZY Biopharma (02496) Announces Monthly Return for October 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1112558527","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112558527?lang=en_us&edition=fundamental","pubTime":"2025-11-06 16:46","pubTimestamp":1762418813,"startTime":"0","endTime":"0","summary":"Wuhan YZY Biopharma Co., Ltd. (02496) published its Monthly Return on Movements in Securities for the period ended 31 October 2025. The total authorized share capital remained at RMB 193,849,200,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"gpt_icon":0},{"id":"2576733570","title":"Wuhan YZY Biopharma Presents Phase II M701 Data for Malignant Pleural Effusion at ESMO 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2576733570","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576733570?lang=en_us&edition=fundamental","pubTime":"2025-10-19 18:31","pubTimestamp":1760869899,"startTime":"0","endTime":"0","summary":"Wuhan YZY Biopharma Co. Ltd. has announced that interim data from its Phase II clinical study of M701, a bispecific antibody drug candidate targeting EpCAM and CD3, for the treatment of malignant pleural effusion  caused by advanced non-small cell lung cancer in China, was presented at the European Society for Medical Oncology  Congress 2025. The data was shared in a poster presentation  and will be available on the company's website. The company noted that the development and marketing of M701 are not guaranteed, and advised shareholders and potential investors to exercise caution.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuhan Yzy Biopharma Co. Ltd. published the original content used to generate this news brief on October 19, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251019:nNDL3w08pw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02496"],"gpt_icon":0},{"id":"1111534019","title":"YZYBIO-B (02496): Mid-Stage Data from Phase II Study of M701 for Malignant Pleural Effusion Presented at ESMO 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1111534019","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111534019?lang=en_us&edition=fundamental","pubTime":"2025-10-19 18:22","pubTimestamp":1760869336,"startTime":"0","endTime":"0","summary":"YZYBIO-B (02496) announced that mid-stage data from its self-developed dual-target bispecific antibody (Bs Ab) M701, targeting epithelial cell adhesion molecule (Ep CAM) and cluster of...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496","BK1161"],"gpt_icon":0},{"id":"1169711477","title":"Wuhan YZY Biopharma (2496) Announces Interim Phase II Results of M701 for Malignant Pleural Effusion","url":"https://stock-news.laohu8.com/highlight/detail?id=1169711477","media":"Bulletin Express","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169711477?lang=en_us&edition=fundamental","pubTime":"2025-10-19 18:22","pubTimestamp":1760869333,"startTime":"0","endTime":"0","summary":"Wuhan YZY Biopharma Co., Ltd. (Stock Code: 2496) presented interim results from a randomized, multi-center, open-label Phase II clinical study (M70103) of its bispecific antibody candidate M701 at...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02496"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":35,"code":"91000000","status":"200"}]}}